Dermatomyositis Terminated Phase 0 Trials for Immune Globulin Human (DB00028)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Terminated0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02271165Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept StudyTreatment